Data Foundry

Drug recalls 2026

Metoclopramide Tablets — Class II drug recall D-0038-2027

Ongoing recall by Teva Pharmaceuticals USA, Inc, reported 2026-10-21, distributed nationwide. Presence of Foreign Tablets/Capsules

Recall numberD-0038-2027
Product typeDrug
ClassificationClass II
StatusOngoing
Voluntary or mandatedVoluntary
Recalling firmTeva Pharmaceuticals USA, Inc, Parsippany, NJ, United States
Recall initiated2026-09-29
Classified2026-10-13
Reported by FDA2026-10-21
DistributedNationwide (US)
Quantity240,448 cartons
NDC00093-2203, 00093-2203-01, 00093-2203-05, 00093-2203-10, 00093-2204, 00093-2204-01, 00093-2204-05
Lot numbers8633085, 8634085, 8635085, 8636085
Expiration dates2027-07

Product

Metoclopramide Tablets, USP, 5 mg, [100 or 500] Tablets per bottle, Rx Only, Manufactured for: Teva Pharmaceuticals, Parsippany, NJ 07054. NDC 100 Tablets: 0093-2204-01; NDC 500 Tablets: 0093-2204-05

Reason for recall

Presence of Foreign Tablets/Capsules

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0038-2027. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-10-27. Not affiliated with or endorsed by FDA. Not medical or legal advice.